[go: up one dir, main page]

PL1778256T4 - Zastosowanie ksenonu jako środka neuroprotekcyjnego u nowo narodzonego osobnika - Google Patents

Zastosowanie ksenonu jako środka neuroprotekcyjnego u nowo narodzonego osobnika

Info

Publication number
PL1778256T4
PL1778256T4 PL05775402T PL05775402T PL1778256T4 PL 1778256 T4 PL1778256 T4 PL 1778256T4 PL 05775402 T PL05775402 T PL 05775402T PL 05775402 T PL05775402 T PL 05775402T PL 1778256 T4 PL1778256 T4 PL 1778256T4
Authority
PL
Poland
Prior art keywords
neuroprotectant
xenon
neonatal subject
neonatal
subject
Prior art date
Application number
PL05775402T
Other languages
English (en)
Other versions
PL1778256T3 (pl
Inventor
Nicholas Franks
Mervyn Maze
Original Assignee
Imperial Innovations Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Innovations Limited filed Critical Imperial Innovations Limited
Publication of PL1778256T3 publication Critical patent/PL1778256T3/pl
Publication of PL1778256T4 publication Critical patent/PL1778256T4/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL05775402T 2004-08-19 2005-08-19 Zastosowanie ksenonu jako środka neuroprotekcyjnego u nowo narodzonego osobnika PL1778256T4 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0418540.1A GB0418540D0 (en) 2004-08-19 2004-08-19 Use
EP05775402.0A EP1778256B1 (en) 2004-08-19 2005-08-19 Use of xenon as neuroprotectant in a neonatal subject
PCT/GB2005/003253 WO2006018655A1 (en) 2004-08-19 2005-08-19 Use of xenon as neuroprotectant in a neonatal subject

Publications (2)

Publication Number Publication Date
PL1778256T3 PL1778256T3 (pl) 2018-09-28
PL1778256T4 true PL1778256T4 (pl) 2018-09-28

Family

ID=33042333

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05775402T PL1778256T4 (pl) 2004-08-19 2005-08-19 Zastosowanie ksenonu jako środka neuroprotekcyjnego u nowo narodzonego osobnika

Country Status (13)

Country Link
US (2) US20090311340A1 (pl)
EP (1) EP1778256B1 (pl)
JP (1) JP5175097B2 (pl)
AU (1) AU2005273641B2 (pl)
BR (1) BRPI0514519A (pl)
CA (2) CA2576156C (pl)
DK (1) DK1778256T3 (pl)
ES (1) ES2674347T3 (pl)
GB (1) GB0418540D0 (pl)
MX (1) MX2007001822A (pl)
PL (1) PL1778256T4 (pl)
PT (1) PT1778256T (pl)
WO (1) WO2006018655A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1830856B1 (en) * 2004-08-02 2012-04-18 John W. Olney Preventing pathological increases in the rate of nerve cell suicide in immature nervous systems
EP1980260A1 (en) 2007-04-10 2008-10-15 Nicholas Peter Franks Use of hyperbaric conditions to provide neuroprotection
EP1980261A1 (en) 2007-04-10 2008-10-15 Nicholas Peter Franks Use of helium with oxygen to provide neuroprotection
RU2583179C2 (ru) * 2011-02-07 2016-05-10 ЭДВАНСТ ПРЕЗЕРВЕЙШНЗ ТЕКНОЛОДЖИЗ, ЭлЭлСи Способ консервации клеток и культур клеток
RU2690450C2 (ru) 2011-09-26 2019-06-03 РИЧ ТЕКНОЛОДЖИЗ ХОЛДИНГ КОМПАНИ, ЭлЭлСи Способ консервации тромбоцитов
CN103565745A (zh) 2012-08-10 2014-02-12 德克萨斯州大学系统董事会 用于治疗中风的神经保护性脂质体组合物和方法
EP4082552A1 (en) 2013-03-15 2022-11-02 The Board of Regents of the University of Texas System Liquids rich in noble gas and methods of their preparation and use
WO2015024100A1 (en) * 2013-08-19 2015-02-26 Schmidt Klaus Michael Non-anesthetic protective gases in combination with liquid anesthetic agents for organ protection
FR3021220B1 (fr) * 2014-05-21 2017-08-25 Air Liquide Association de xenon et d’un antioxydant pour lutter contre une maladie neurodegenerative de type maladie de parkinson
US10828436B2 (en) * 2016-04-05 2020-11-10 Vanderbilt University Administering the noble gas argon during cardiopulmonary resuscitation
KR20210034008A (ko) * 2018-07-18 2021-03-29 라이크마인즈, 인크. 뇌로의 화합물의 가속화된 조직 침투를 위한 방법
US20220087970A1 (en) * 2019-01-18 2022-03-24 The Johns Hopkins University Prevention of anesthetic-induced neurocognitive dysfunction
WO2023287726A1 (en) 2021-07-12 2023-01-19 Penland Foundation Treatment of cancer using botulinum toxin and nitrous oxide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19933704A1 (de) * 1999-07-19 2001-01-25 Michael Georgieff Verwendung einer lipophile Gase enthaltenden Präparation zur Neuroprotektion und Neuroregeneration
US6653354B2 (en) * 1999-07-29 2003-11-25 Protexeon Limited NMDA antagonist comprising xenon
DE10045829A1 (de) * 2000-09-14 2002-04-04 Messer Griesheim Gmbh Volatile Anästhesiemittel mit Xenon
GB0209998D0 (en) 2002-05-01 2002-06-12 Protexeon Ltd Use
GB0218153D0 (en) 2002-08-05 2002-09-11 Ic Innovations Ltd An analgesic agent for newborn or retal subjects
PT1670489E (pt) 2003-10-10 2008-02-28 Protexeon Ltd Utilização de xénon com hipotermia para o tratamento de asfixia neonatal

Also Published As

Publication number Publication date
EP1778256B1 (en) 2018-03-21
PL1778256T3 (pl) 2018-09-28
JP2008509981A (ja) 2008-04-03
US20150216897A1 (en) 2015-08-06
JP5175097B2 (ja) 2013-04-03
CA2576156C (en) 2013-11-12
DK1778256T3 (en) 2018-07-02
PT1778256T (pt) 2018-07-25
AU2005273641B2 (en) 2011-10-20
EP1778256A1 (en) 2007-05-02
AU2005273641A1 (en) 2006-02-23
CA2576156A1 (en) 2006-02-23
ES2674347T3 (es) 2018-06-29
US20090311340A1 (en) 2009-12-17
WO2006018655A1 (en) 2006-02-23
US9326996B2 (en) 2016-05-03
BRPI0514519A (pt) 2008-06-10
MX2007001822A (es) 2007-10-10
CA2781626C (en) 2016-07-05
GB0418540D0 (en) 2004-09-22
CA2781626A1 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
IL183101A0 (en) Use of cannabinoids in the manufacture of medicaments
EP2015718A4 (en) EXTERNAL PENIS COMPRESSION CUFF WITH ABSORPTION BAG
EP1785131A4 (en) EXTERNAL PREPARATION OF TYPE S / O
IL178029A0 (en) Use of sulfonylureas
IL183929A0 (en) Use of inerferon - ?? in the preparation of a medicament
EP1722726A4 (en) orthosis
GB0427313D0 (en) Cuff
ZA200710551B (en) Use of sanglifehrin in HCV
PL1778256T4 (pl) Zastosowanie ksenonu jako środka neuroprotekcyjnego u nowo narodzonego osobnika
EP1725198A4 (en) IMPROVED CONDOM FOR WOMEN
IL184008A0 (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
IL176975A0 (en) Physical user interface
GB2416124B (en) Functional hand splint
PL2215908T3 (pl) 2-alkilo-cykloalk(en)ylo-karboksamidy i ich zastosowanie jako fungicydów
ZA200904755B (en) Use of epothilones in the treatment of osteoporosis and related diseases
EP1804646A4 (en) CORNEAL BIOMETRY
GB0704338D0 (en) Improvements in or relating to plies
GB0711875D0 (en) Use of a cloth
IL182213A0 (en) Corneal biometry
GB2412360B (en) Artificial hands
GB0409257D0 (en) Disease models and uses thereof
ZA200704650B (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
AP2006003734A0 (en) Inhalation formulation
GB0408891D0 (en) Inflatable cot
IL185755A0 (en) Noninvasive measurements in a human body